Kymera Therapeutics
Highly Engaged Employees
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
200 Arsenal Yards Blvd Ste 230, Watertow...Phone Number
(857) 285-5300Website
www.kymeratx.comRevenue
$105 MillionStock Symbol
KYMRIndustry
About Kymera Therapeutics
Kymera Therapeutics is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in Watertown, Massachusetts. The company specializes in research and development of targeted protein degradation therapeutics, a novel approach to address previously untreatable disease targets. Kymera's proprietary Pegasus platform facilitates the discovery of small molecule degraders that utilize the body's natural protein recycling machinery to eliminate disease-causing proteins. The company focuses on developing treatments for immune-inflammatory diseases, blood cancers, and solid tumors through its lead programs targeting IRAK4, IRAKIMiD, and STAT3 pathways. As a publicly traded company on Nasdaq, Kymera aims to become a fully integrated biopharmaceutical organization pioneering protein degrader medicines for conditions with significant unmet medical needs.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: KYMRShow moreKymera Therapeutics Org Chart
Compare Similar Companies to Kymera Therapeutics
Compare insights from companies similar to Kymera Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$50.7M
51-200
Private
-
1999
AO
Aram OganesianVice President, Clinical Pharmacology & Nonclinical Development
Kymera Therapeutics Tech Stack
A closer look at the technologies used by Kymera Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Kymera Therapeutics
Sign Up For FreeTo access detailed company insights
Kymera Therapeutics is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in Watertown, Massachusetts. The company specializes in research and development of targeted protein degradation therapeutics, a novel approach to address previously untreatable disease targets. Kymera's proprietary Pegasus platform facilitates the d... Read More

